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Stunned myocardium can be produced by repeated short
episodes of ischemia. Histochemical and ultrastructural
abnormalities such as sarcomere lengthening and myofi-
ber thinning have been noted in myocardium soon after
the onset of ischemia and have been attributed to the
mechanical stretching that occurs during ventricular
systole. To test whether mechanical forces alone could
produce the residual dysfunction seen in stunned myo-
cardium, regional dyskinesia was produced in open chest
dogs by six repeated intracoronary infusions of either
potassium chloride, 0.2 mEq/min for 2.5 minutes, or
lidocaine, a 10 mg bolus followed by 1 to 3 mg/min for
5 minutes. These dogs were matched with dogs that had
six repeated coronary occlusions of 2.5 and 5 minutes'
duration, respectively. Regional function was analyzed
Within seconds of a coronary artery occlusion, active con-
traction ceases and the ischemic myocardium is subjected
to mechanical forces during each systole that result in myo-
cardial segment lengthening, and probably sarcomere
stretching and myofiber thinning, Studies have shown that
end-diastolic segment lengthening occurs after a single 5
minute coronary artery occlusion (1), and increases in sar-
comere lengths have been reported after 15 minutes of isch-
emia (2-7). Bouchardy and Majno (2) described a defor-
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using fractional systolic shortening and the load-inde-
pendent end-systolic pressure-length relation.
Both potassium chloride and lidocaine produced re-
gional dyskinesia that was similar to the dyskinesia
produced by coronary occlusion. Although regional ven-
tricular function after repeated coronary occlusions re-
mained significantly reduced, function returned com-
pletely to normal within 5 minutes after the last drug-
induced dyskinesia. In conclusion, regional dysfunction
produced by potassium chloride and lidocaine does not
produce residual dysfunction despite mechanical forces
during systole similar to those seen during coronary oc-
clusion.
(J Am Coli CardioI1987;9:1339-47)
mation of the myocardial fibers termed "wavy fibers" that
appear in nonnecrotic areas after ischemic dyskinesia. The
pathogenesis of wavy fibers and sarcomere lengthening ap-
pears to be the repeated mechanical stretching of the isch-
emic region during ventricular systole.
In previous studies (8,9) we produced severe postisch-
emic regional dysfunction by repeated, short coronary oc-
clusions that subjected the myocardium to multiple episodes
of systolic stretching. Heyndrickx et al. (1) demonstrated a
significant increase in both end-diastolic and end-systolic
segment lengths that persisted up to 3 hours after a single
5 minute coronary occlusion. The recovery of regional sys-
tolic function coincided with the normalization of segment
lengths, suggesting that postischemic dysfunction may have
been caused by ultrastructural abnormalities resulting from
regional systolic stretching. The purpose of this study was
to assess the contribution that repeated periods of mechan-
ical stretching alone, independent of ischemia, have on the
systolic dysfunction seen in stunned myocardium by using
a model of nonischemic regional dyskinesia produced by
0735-1097/87/$3.50
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Figure I. Experimental model. Intracoronary drug infusionswere
performed through a small Silastic cannula inserted into the left
anterior descending coronary artery. Repetitive coronary occlu-
sions were produced by a snare occluder. Ultrasonic crystal pairs
in the ischemic and nonischemic zones were used to measure
regional function .
ExperimentII. A second protocol was performed in an-
other group of animals to produce longer periods of dys-
kinesia . Six dogs received a 10 mg intracoronary bolus of
lidocaine (10) over 15 seconds followed by a continuous
infusion of I to 3 mg/min to maintain maximal regional
dyskinesia for 5 minutes, alternating with 10 minute recov-
ery periods, repeated six times, followed by a final 60 min-
ute recovery period. After the final recovery period, six 5
minute coronary artery occlusions were performed at the
point of cannulation, alternating with 10 minute reflow pe-
riods , followed by a final 60 minute reflow period.
Measurements. For both experiments, blood flow to
ischemic and normal myocardium was determined by ra-
dioactive microspheres (15 J-Lm diameter, New England Nu-
clear) , labeled with cerium-141, tin-113, ruthenium-I03,
niobium-95 or scandium-46 and injected into the left atrium .
Three to five million microspheres were injected after a 3
minute mechanical agitation , whereas reference arterial
samples were withdrawn at a constant rate of 2.16 mllmin
by a calibrated pump . Blood flow was calculated from the
radioactivity in tissue and reference blood samples deter-
mined in a well-type gamma scintillation counter (Packard
model 5986) using standard methods after correction for
overlap of the different radionuclide energy peaks . In each
dog , flows to ischemic and normal zones represented mea-
surements in single tissue blocks weighing I to 3 g, divided
into endocardial and epicardial halves and encompassing
each crystal pair. Flows were measured before and after the
insertion of the Silastic cannula , during peak dysfunction
resulting from either KCl, lidocaine or coronary occlusion
and at the end of the final reflow period .
intracoronary administration of potassium chloride (KCI) or
lidocaine .
Methods
Animal model. Eighteen mongrel dogs of either sex (20
to 26 kg) were anesthetized with intravenous sodium thia-
mylal (12.5 mg/kg body weight) and intramuscular alpha-
chloralose (100 mg/kg) in urethane , intubated and ventilated
with room air at a constant volume with a piston respirator.
After a thoracotomy in the left fifth intercostal space, the
lungs were retracted and the heart was exposed through a
pericardiotomy.
Pairs of 5 MHz cylindrical piezoelectric crystals (0.06
inch [0.152 em] outside diameter, 0.06 inch length, 0.015
inch [0.038 em] thick; Vernitron) were implanted in myo-
cardium served by the left anterior descending coronary
artery and in the anterolateral-basal region within the cir-
cumflex artery territory . The crystals were implanted in the
midwall of the left ventricle , 10 to 15 mm apart, and were
oriented parallel to the minor axis . Segment lengths were
measured with a pulse transit sonomicrometer (model Sono-
I-XB, James Davis Consultants). Left ventricular pressure
and its first derivative with respect to time, left ventricular
dP/dt , were measured with a catheter tip pressure transducer
(Millar) that was inserted through an implanted silicone
rubber left atrial catheter and advanced across the mitral
valve. Aortic pressure was measured with a Statham P23-
10 transducer (Gould Statham , Inc.) . Catheters were placed
in the descending aorta for blood pressure measurement and
withdrawal of microsphere reference samples, in the left
atrium for microsphere injections and in the femoral vein
for infusion of fluids. Pressures, segment lengths and lead
II of the electrocardiogram (ECG) were recorded continu-
ously on a direct writing recorder (Gould Brush 200). A
Silastic tube (0.012 inch [0.0305 ern] internal diameter,
0.025 inch [0.064 em] external diameter; Dow-Corning)
was introduced into the anterior descending artery just distal
to the first diagonal branch, and 0.9% sodium chloride was
infused at 0.3 ml/min by a constant infusion pump (Harvard
Apparatus Corporation) . A snare occluder was placed just
distal to the insertion of the cannula (Fig. I) .
Experimental protocol. Experiment I. Ten dogs re-
ceived intracoronary infusions of potassium chloride (KCI)
at approximately 0.2 mEq/min to produce maximal regional
dyskinesia for 2.5 minutes, followed by a 10 minute re-
covery period , repeated six times with a final 10 minute
recovery time. To compare the effects of multiple coronary
occlusions with those of repeated KCI infusions, six addi-
tional dogs had a snare occluder placed around the left
anterior descending artery at the point of the insertion of
the Silastic cannula and were subjected to coronary occlu-
sions of 2.5 minutes followed by 10 minute reflow periods,
repeated six times with a final 10 minute recovery period.
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Hemodynamic and ultrasonic crystal measurements were
made at end-expiration during thefollowing periods: before
and after insertion of the Silastic cannula, at the end of each
period of dyskinesia and at the end of each recovery or
reflow period.
Postmortem myocardial examinations. After the ex-
perimental protocol, the animals were killed by intraatrial
injection of KCI. The hearts were cut into five to six short-
axis slices from apex to base, each of which was incubated
at 37°C in triphenyltetrazolium chloride for 20 minutes and
photographed in color. The site of each ultrasonic crystal
pair was marked with a needle for photography. After this,
the site of each crystal pair was excised, weighed and counted
for radioactivity for measurement of blood flow. The fresh
tissue and photographs were both inspected to identify un-
stained areas, representing myocardial necrosis. Four ani-
mals sustained ventricular fibrillation during KCI infusion
and were excluded from data analysis .
Analysis of function. Signals from the ultrasonic crys-
tals , left ventricular pressure and left ventricular dP/dt were
routed to a microcomputer (North-Star Horizon) at selected
times during the experiment, digitized at 150 Hz by a Tee-
mar 12 bit analog-to-digital converter and recorded on a
floppy disk for later computerized analysis. The end-systolic
segment length was measured 20 ms before peak negative
left ventricular dP/dt (II); end-diastolic length was mea-
sured just before the onset of positive left ventricular dP/dt.
To characterize regional systolic function, percent systolic
shortening and percent systolic bulging (12) were used .
Percent systolic segmental shortening was calculated as seg-
ment shortening (end-diastolic minus end-systolic length)
divided by end-diastolic segment length times 100, whereas
percent systolic bulging was defined as (maximal segment
length - end-diastolic length) -7- end-diastolic length x
100. Each measurement represented the average of at least
five heartbeats.
Data for calculating the end- systolic pressure-length re-
lation was obtained as left ventricular pressure rose during
a gradual manual occlusion of the descending thoracic aorta .
Left ventricular pressure and ultrasonic crystal segment length
data were collected over a 7 second period just before and
during the rise in left ventricular pressure . For each cardiac
cycle, instantaneous left ventricular pressure and ultrasonic
crystal segment length data were used to calculate the slope
and the length-axis intercept, respectively, of the end-sys-
tolic pressure-length relation as defined by: Ees = Pes/(Les
- LO) , where Ees = slope of the end-systolic pressure-
length relation, Pes = left ventricular pressure at end-sys-
tole, Les = segment length at end-systole and LO = length-
axis intercept of the end-systolic pressure-length relation
(13). For each cardiac cycle the left ventricular pressure-
length point that maximized the value of the slope of the
end-systolic pressure-length relation was taken as the end-
systolic pressure length point. End-systolic pressure-length
points from each beat were then used to determine the best
least-squares linear regression from which the variables Ees
(slope) and LO(intercept) were calculated to define the end-
systolic pressure-length relation . Iterations were repeated
until both Ees and LO were constant.
Although Ees and LO define the end-systolic pressure-
length relation . it should be noted that LO was calculated
from data collected over a relatively narrow range of end-
systolic left ventricular pressures (usually between 90 and
160 mm Hg). Thus, to estimateLO an extrapolation of at
least 90 mm Hg was required . As an alternative the end-
systolic pressure-length relation can be defined by a slope
and a calculated end-systolic length at any end-systolic pres-
sure (13). Because the pressure-length data were collected
at >90 mm Hg end-systolic pressure, we used the calculated
end-systolic length at a left ventricular pressure of 100 mm
Hg (L I00) as the length-axis intercept.
Data analysis. Data are presented as means ± SO. Se-
quential measurements in both the ko and lidocaine ex-
periments were compared using a repeated measures anal-
ysis of variance, and significant differences were determined
by a Neuman-Keuls test. Comparisons between dogs that
received intracoronary KCI and dogs that received repeated
2'12 minute coronary occlusions were made using unpaired
t tests. Differences in the end-systolic pressure-length re-
lation were defined by comparing the sequential calculated
slope (Ees) of this relation and the end-systolic lengths at
left ventricular pressures of 100 using a repeated measures
analysis of variance.
Results
Effect of coronary cannulation. Cannulation of the left
anterior descending coronary artery with the small Silastic
tubing did not produce changes in regional myocardial blood
flow or function. Occasional episodes of coronary vaso-
spasm were noted after cannulation and were treated by
applying a small volume of dilute nitroglycerin to the ex-
ternal surface of the coronary vessel .
Experiment I: Changes During Intracoronary KCI
Versus Repeated Coronary Occlusions
Intracoronary potassium chloride (KCI) was infused in
six dogs to produce 2.5 minutes of maximal regional dys-
kinesia followed by 10 minute recovery periods, repeated
six times . These were compared with six dogs that received
repeated 2.5 minute coronary occlusions alternating with 10
minute reflow periods, repeated six times .
Hemodynamics. Intracoronary KCI produced a signif-
icant decrease in peak left ventricular pressure (119 ± 23
mm Hg at baseline versus 106 ± 24 mm Hg during KCI
infusion, p < 0.05), whereas mean aortic pressure, heart
rate and left ventricular end-diastolic pressure remained un-
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Table 1. Hemodynamic Effects of Regional Potassium Chloride- and
Ischemia-Induced Dyskinesia
Coronary
KCI-IC Occlusion
Baseline (n = 6) Recovery Baseline (n = 6) Reflow
Peak LV 11 9 ± 23 106 ± 24* 11 3 ± 23 116 ± 12 109 ± 14* 11 8 ± 17
pressure
(mm Hg)
Mean aortic 96 ± 23 89 ± 27 93 ± 19 94 ± 13 86 ± 17 92 ± 17
pressure
(mm Hg)
Heart rate 125 ± 21 123 ± 16 118 ± 20 135 ± 25 137 ± 23 122 ± 26
(beats/min)
*p < 0.05 comparedwith baseline. IC = intracoronary; KCI = potassium chloride;LV = left ventricular.
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changed, The animals that received repeated coronary oc-
clusions equal in duration to the KCl infusions showed a
decrease in peak left ventricular pressure (116 ± 12 mm
Hg at baseline versus 109 ± 14 mm Hg during occlusion,
p < 0.05). Mean aortic pressure, heart rate and left ven-
tricularend-diastolicpressurewereunchanged frombaseline
values. There was no difference (unpaired t test) in hemo-
dynamic variables between the KCI infusion and coronary
occlusion groups (Table 1).
Regional dysfunction. During KCl infusion into the left
anterior descending region, systolic shortening decreased
from a baseline value of 18.3 ± 6.5% to -7.7 ± 3. 1%
(p < 0.005) (Fig. 2 and 3). The end-diastolic segmentlength
in the left anterior descending region was increased by KCl
infusion (13.6 ± 1.2 mm at baseline versus 14.0 ± 1.3
mm during infusion, p < 0.05) , whereas the end-systolic
length increased from 10.9 ± 1.2 mm at baseline to 15.3
± 1.4 mm (p < 0.005) . Percent systolic bulging was 17
± 7% with a maximal segment length of 16.1 ± 1.7 mm.
In the repeated coronary occlusion experiments , systolic
function decreased from 15.6 ± 5.9% at baseline to -8.5
± 3.2% (p < 0.005) (Fig. 2) as end-systolic segmentlength
increased from 10.6 ± 2.2 to 14.8 ± 2.0 mm (p < 0.005)
and end-diastolic segment length increased from 12.5 ±
2.3 to 13.8 ± 2.2 mm (p < 0.05). Percent systolic bulging
was 12.3 ± 5.7% with a maximal segment length of 15.4
± 1.9 mm.
The changes in end-systolic, end-diastolic and maximal
segment length from baseline to maximal dyskinesia were
similar for KCl infusion and coronary occlusion in the re-
peated ischemiaexperiments, reflecting an equal amount of
mechanical stretching (unpaired t test).
Control segments showed no change in systolic short-
ening or segment length during either KCI infusion or coro-
nary occlusion.
Regional myocardial blood flow. Intracoronary KCI did
not change myocardial blood flow whereas coronary occlu-
sion reduced flow to < 10% of baseline values, with en-
docardial flow reduced significantly more than epicardial
flow (p < 0.05) (Table 2).
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Figure 2. Fractional systolic shortening forthe 10po-
tassium chloride (KCl)-treated dogs and 6 dogs
undergoing repetitive coronary occlusions at baseline,
during KCI infusion or coronary occlusion and 5 and
10 minutes after the sixth infusion or occlusion. The
amount of dyskinesia was similar between ischemic
and drug-induced dysfunction. Systolic shortening re-
turned to baseline levels after KCI infusions but was
significantly below baseline after repeated occlusions
(p < 0.(05 ). EDL and ESL = end-diastolic and end-
systolic segment length, respectively.
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Figure 3. The left ventricular pressure (LVP) and re-
gional function , determined by sonomicrometer crys-
tals, are shown during intracoronary potassium chloride
(Kel) infusion and coronary occlusion at the same site
in the same dog . The segment length changes through-
out the cardiac cycle are similar between drug-induced
and ischemic dyskinesia.
LVP
(mmHg)
SEGMENT
LENGTH
(rnm)
1_ _ KCl I
r--- In f us ion-
I _ Co r on ary _I
r--Oc c lus ion"l
Blood Flow (ml/min per g)
*p < 0.05 compared with endocardial value. Abbreviations as in
Figure 1.
Table 2. Myocardial Blood Flow in the Left Anterior
Descending Artery Region During Drug-Induced and
Ischemic Dysfunction
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Figure 4. A, For all Experiment I dogs combined, the mean end-
systolic pressure-length relations at baseline (solid line ) and 10
minutes after repeated coronary occlusions (dashed line) are shown.
A significant shift to the right is seen, reflecting decreased per-
formance. B, There is no change in the end-systolic pressure-l ength
relation between baseline (solid line) and 10 minutes after repeated
potassium chloride infusions (dashed line ).
Experiment IJ: Changes During Repeated
Intracoronary Lidocaine Infusion s Versus Repeated
Coronary Occlusions
In six dogs, intracoronary lidocaine was infused to produce
5 minutes of regional dyskinesia followed by a 10 minute
recovery period, repeated six times. After a final 60 minute
recovery period, six cycle s of 5 minute coronary occlusions
and 10 minute reflow period s were performed.
Hemodynamics. There was no change in peak left ven-
tricular pressure, mean aortic pressure , left ventricular end-
Epicardium
1.2 ± 0.8
1.1 ± 0.6
0 .2 ± 0.2*
1.1 ± 0.4
1.3 ± 0.6
0.09 ± 0.06*
Endocardium
1.0 ± 0.7
1.1 ± 0 .6
0. 06 ± 0.04
1.0 ± 0 .3
1.1 ± 0 .5
0.05 ± 0 .04
Experiment I
Baseline
KCI-IC (n = 6)
Occlusion (n = 6)
Experiment II
Baseline
Lidocaine-IC (n = 6)
Occlu sion (n = 6)
Regional blood flow returned to normal 10 minutes after
the final brief coronary occlu sion. Control region flows were
unchanged during the experiment.
Regional function after final dyskinetic period. Five
minutes after the final KCI infusion, regional function and
segment lengths had returned to normal. Systolic shortening
(17.3 ± 5. 1%) and the end-systolic pressure-length relation
in the left anterior descending region, 5 and 10 minutes after
the final KCI infusion, were similar to baseline levels (Fig.
2 and 4). The end-diastolic segment length (13 .6 ± 1.2
mm baseline versus 13.3 ± 1.6 mm) and end-systolic seg-
ment length (10 .9 ± 1.2 mm baseline versus 10.9 ± 1.2
mm) had also returned to baseline levels 10 minutes after
the final infusion.
In contrast, 5 and 10 minutes after the final short coro-
nary occlusion, systolic shortening remained significantly
less than baseline (15.6 ± 5.9% versus 5.5 ± 6.2%, p <
0.005), whereas the end-systolic pressure-length relation
showed a significant shift to the right (Li OO at baseline 10.3
± 2.1 versus 11.7 ± 2.5 mm 10 minutes after the final
occlusion, p < 0 .05) along with a decrease in slope (50 ±
4.1 versus 25 ± 3.8 mm Hg/mm , p < 0 .05) indicating
decreased regional performance (Fig. 2 and 4). Both the
end-diastolic segment length (12.5 ± 2.3 versus 13.0 ±
2.6 mm, p < 0.05), and the end-systolic segment length
(10.6 ± 2.2 versus 12.3 ± 2.7 mm, p < 0 .05) increased
from baseline to 10 minutes after the final occlusion. All
variables of regional systolic function were unchanged in
the control regions.
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Table 3. Hemodynamic Effects of Lidocaine and Ischemic Dysfunction
Coronary
Lidocaine-IC Recovery, Occlusion Reflow,
Baseline (n = 6) 60 min (n = 6) 60 min
Peak LV 120 ± 23 117 ± 25 123 ± 27 121 ± 23 126 ± 21
pressure
(mm Hg)
Mean aortic 95 ± 26 93 ± 26 98 ± 27 95 ± 27 99 ± 21
pressure
(mm Hg)
Heart rate 121 ± 20 123 ± 21 120 ± 18 120 ± 17 119 ± 28
(beats/min)
Abbreviations as in Table I .
diastolic pressure or heart rate among baseline conditions
regional dyskinesiawith intracoronary lidocaine or coronary
occlusion, and conditions 60 minutes after the final drug
infusion or coronary occlusion. The peak left ventricular
pressure was 117 ± 25 mm Hg during lidocaine infusion
and 121 ± 23 mm Hg during coronary occlusion; mean
aortic pressurewas93 ± 26 mm Hgduring lidocaine admin-
istration and 95 ± 27 mm Hg during coronary occlusion
(Table 3).
Regional dysfunction. Intracoronary lidocaine infusion
into the left anterior descending region produced rapid re-
gional dyskinesia that was sustainedfor 5 minutes (Fig. 5).
Systolicshorteningdecreasedfrom a baseline value of 22.5
± 3.4% to -10.9 ± 4.4% during lidocaine infusion (p <
0.005). End-diastolic segment length increased from 12.4
± 1.9 mm at baseline to 13.9 ± 2.2 mm, and the end-
systolic segment length increased from 9.6 ± 1.9 mm to
15.5 ± 2.6 mm (p < 0.05 for bothcomparisons). Coronary
occlusion at the insertion of the intracoronary cannula produced
a decrease in systolic shortening to -10.7 ± 4.1% (Fig.
6), with an end-diastolic segment lengthof 14.1 ± 2.4 mm
and an end-systolic segment length of 15.7 ± 3.0 mm (p
< 0.05 for all values compared with baseline), which were
similar to the values measured during lidocaine infusion
(repeated measures analysis of variance). The percent sys-
tolic bulging was 13.9 ± 2.5% during lidocaine infusion
and 13.5 ± 2.3% during coronary occlusion; the maximal
segment length was 16.1 ± 2.5 mm during lidocaine, and
15.8 ± 2.6 rom during occlusion. The control region showed
no change in systolic shortening during lidocaine infusion
or coronary occlusion.
Regional myocardial blood flow. Flow in the left an-
terior descending region was unchanged by intracoronary
lidocaine infusion , but was reduced to approximately 10%
of baseline values during coronaryocclusion with endocar-
dial flow reduced significantly more than epicardial flow (p
< 0.05) (Table 2). Sixty minutes after the final occlusion
period, flow had returned to baseline values. Flow in the
control region was unchanged during the experiment.
Function after the final dyskinetic period. After the
final lidocaine infusion, systolic shortening, end-diastolic
segment length, end-systolic segment length and the end-
systolicpressure-length relationin the left anteriordescend-
ing region all returned to baseline values within 5 minutes
(Fig. 6 and 7). However, after the finalS minute coronary
occlusion, systolic shortening remaineddepressed to 4.7 ±
6.7% even after 60 minutes (p < 0.005 compared with
baseline and the end-systolic pressure-length relation showed
a significant shift to the right indicating persistently de-
creased regional contractility (Fig. 7). The length-axis in-
tercept was 9.5 ± 1.8 mm at baseline, 9.2 ± 1.8 mm 60
minutes after lidocaine and 11 .5 ± 2.7 mm 60 minutes
after the final coronaryocclusion (p < 0.05 compared with
baseline and postischernic values). The slope of the end-
systolic pressure-length relation was 49 ± 3.6 mm Hg/mrn
at baseline, 42 ± 3.9 mm Hg/mm after lidocaine and 29
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Figure 5. The left ventricular pressure and sonomi-
crometer measurements during intracoronary lidocaine
infusion and coronary occlusion in the same dog are
shown revealing similar segment length changes
throughout the cardiac cycle. The brief elevation inleft
ventricular pressure is a result ofaortic (Ao) occlusion
during measurement ofthe end-systolic pressure-length
relation (ESPLR). LVP = left ventricular pressure.
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Figure 6. Fractional systolic shortening for the six
lidocaine-treated dogs is shown. Despite similar dys-
kinesia between drug-induced and ischemic dysfunc-
tion, shortening was significantly below baseline after
repeated occlusions (p < 0.(05) butreturned to base-
line levels after repeated lidocaine infusions. Abbre-
viations as in Figure 2.
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± 3.8 mm Hg/mm after coronary occlusion (p < 0.05
comparedwith baselineand postischemic values). The end-
diastolic segment length remained increased to 13.5 ± 2.2
mm, and the end-systolic segment length to 12.9 ± 2.4
mm 60 minutesafter the final coronaryocclusion(p < 0.05
compared with baseline for both lengths). The control seg-
ments showed no change in systolic shortening, end-dia-
stolic and end-systolic segment length or the end-systolic
pressure-length relation.
Myocardial necrosis. In all animals, visual inspection
of the triphenyltetrazolium chloride-stained left ventricular
slices showed no areas of necrosis.
Figure 7. For all Experiment II dogs combined, the mean end-
systolic pressure-length relation atbaseline (solid line), 60m!nutes
after thelast lidocaine infusion (dashed line at left) and 60minutes
after thefinal coronary occlusion (dashed line at right) areshown.
A significant shift to theright, indicating decreased regional per-
formance, is seen after repeated occlusions. After repeated lido-
caine infusions, the end-systolic pressure-length relation was un-
changed from baseline.
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Discussion
The major finding of this study was that short repetitive
episodes of drug-induced regional dyskinesia failed to produce
the same residual dysfunction or myocardial "stunning"
seen with repeated episodes of coronary occlusion. Both
KCl and lidocaine infused into the left anteriordescending
artery producedregional dyskinesia that was similar to that
produced by coronary occlusion, without a change in re-
gional myocardial blood flow. During the drug-induced
dyskinetic periods, the myocardium was subjected to similar
hemodynamic stresses as during coronary occlusions be-
cause peak left ventricular systolic pressure, mean aortic
pressure and heart rate were similar during drug infusions
and coronaryartery occlusions. Alterations in regional end-
diastolic and end-systolic segment lengths were also quan-
titatively similar, suggesting equal mechanical stretching
during ischemic and nonischemic dyskinesia. However, as
systolic shortening and the end-systolic pressure-length re-
lation returned to baseline values after each drug-induced
dyskinetic period, function aftersix repeated2.5 or 5 minute
coronary occlusions remained significantly depressed, con-
sistent with the appearance of stunned myocardium.
Experimental limitations. It is clear from the data that
both potassium chloride (KCI) and lidocaine produced re-
gionaldysfunction thatmimicked the dysfunction seenwhen
the coronary artery was occluded at the point of infusion
(Fig. 3 and 5). Myocardial stretching should be reflected in
segment lengthening, and end-diastolic, end-systolic and
maximal segment lengths were similar in drug- and isch-
emia-induced dysfunction. Although comparisonof the seg-
ment lengths at three points in the cardiaccycle cannot fully
reflect the dynamics of the entire cardiac cycle, Figures 3
and 5 show that KCl and lidocaine produced bulging that
appeared identical throughout systole to that produced by
coronary occlusion.
No estimates of "risk region" size were performed be-
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cause it was difficult to accurately estimate the extent of
KCl or lidocaine diffusion. We reasoned, however, that
because the KCl and lidocaine were infused into the unob-
structed anterior descending coronary artery, it was probably
carried throughout the perfusion territory of that artery and
remained confined to the left anterior descending region.
We, therefore, assumed that the zones of dysfunction were
equivalent in size between drug infusion and ischemia.
However, if the size of the affected regions did differ, dif-
ferences might also have occurred in regional wall stress,
ventricular shape and regional loading conditions, producing
differences in regional myocardial strain. Global measures
of left ventricular function were similar, lending support to
the notion that the size of the affected regions were com-
parable.
The duration of dysfunction induced by KCl and lido-
caine was measured only while maximal bulging was main-
tained and was not equal to the duration of infusion. Isch-
emic time was measured from the time of occlusion to
release. Therefore, because KCl was titrated to produce
gradual and progressive dysfunction to avoid arrhythmias,
and the effects of KCl and lidocaine could not be reversed
as rapidly as those of ischemia, the duration of abnormal
regional function was actually greater with KCl and lido-
caine and the actual recovery time between repeated infu-
sions was slightly shorter than between coronary occlusions.
In previous studies (8,9) we used 12 to 16 5 minute
coronary occlusions to produce severely stunned myocar-
dium without ulstrastructural evidence of necrosis. Although
we found the degree of myocardial stunning to be cumulative
with repeated occlusions, considerable stunning was often
apparent after only one or two occlusions (8,9). In the pres-
ent study, to reduce the risk of arrhythmias during KCl
infusion and minimize the cumulative negative inotropic
effect of lidocaine, we chose a protocol in which 6 rather
than 12 to 16 periods of drug infusion were used and com-
pared with 6 periods of coronary occlusion of equal duration.
However, this protocol was clearly sufficient to demonstrate
a marked degree of myocardial stunning after the coronary
occlusions but no evidence at all of stunning after the drug
infusions.
Other studies on myocardial flow and contractile per-
formance. Both KCl and lidocaine produced a profound
reduction in contractile performance without a change in
myocardial blood flow. One might have anticipated a de-
crease in blood flow because of the marked decrease in
myocardial oxygen demands, but the actual level of regional
flow in this model is determined by a complex interaction
between regional oxygen demands, vascular factors and ex-
travascular wall stress. Because of the inhibitory effects of
KCl and lidocaine on vascular smooth muscle contraction
(14), it is likely that vascular tone was reduced and auto-
regulation of the vascular bed attenuated. Extravascular wall
stress may have been reduced because of the elimination of
systolic contraction, or increased because of the forces ex-
erted on the affected myocardial segment by contraction of
normal segments. In the study of Marzilli et al. (15), intra-
coronary lidocaine given during maximal vasodilation in-
duced by adenosine resulted in a reduction in contractility
and an increase in coronary flow. In our study, the effects
of reduced contraction on wall stress may have been ob-
scured by important changes in vascular tone.
Conclusions. Repeated drug-induced regional dyskine-
sia, although producing similar mechanical stresses, did not
produce the sustained, residual dysfunction that was seen
after repeated coronary occlusions. Thus, mechanical
stretching, in the absence of ischemia, does not appear to
be an independent factor contributing to the appearance of
stunned myocardium.
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